EVT0185
Product Specifications
CAS Number
2588489-03-4
Target
ATP Citrate Lyase
Related Pathways
Metabolism
Bioactivity
EVT0185 is an orally active ATP citrate lyase (ACLY) inhibitor. In the liver, it is converted by SLC27A2 into a CoA thioester, which interacts with the CoA binding site of ACLY. EVT0185-CoA inhibits ACLY activity with an IC50 of 2.5 μM. It mimics the immune and antitumor effects seen with ACLY gene deletion. Additionally, EVT0185 elevates levels of tumor-infiltrating B cells and the chemokine CXCL13. It is applicable in cancer research, including hepatocellular carcinoma (HCC) .
Smiles
O=C(O)C(C)(C)CCCCC1=CC=C(C=C1)CCCCC(C(=O)O)(C)C
Molecular Formula
C22H34O4
Molecular Weight
362.5
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
M2354-88E-ML750 100 µL
MAPKAP1 (Mitogen-activated Protein Kinase 2-associated Protein 1, Mitogen-activated Protein Kinase Associated Protein 1, MIP1, Stress-activated Map Kinase-interacting Protein 1, SAPK-interacting Protein 1, mSIN1, SIN1, Target of Rapamycin Complex 2 Subunit MAPKAP1, TORC2 Subunit MAPKAP1) (MaxLight 750) discontinued
Sign In for Pricing
View Details 